Observation of the Use of QUTENZA™ in Standard Clinical Practice
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This non-interventional study will evaluate the efficacy, tolerability, health related
quality of life and use of health resources associated with QUTENZA treatment when QUTENZA is
used in standard clinical practice.
The patient's primary diagnosis of peripheral neuropathic pain (PNP) will be classified into
subtypes: post-herpetic neuralgia (PHN); HIV-associated neuropathy (HIV-AN); neuropathic back
pain; cancer-related neuropathic pain; post-operative & post-traumatic neuropathic pain; and
'other' neuropathies.